Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsPoint-of-care diagnosis of tuberculosis: past, present and futureComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyWhat is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluationTime to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaThe diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in MalaysiaMolecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in BangladeshCorrelation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility resultsImpact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trialCatching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaImplementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 CountriesThe diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceCorrelation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden settingConfronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from MalaysiaImpact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound.Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings.Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients.Evaluation of the MTBDRplus 2.0 assay for the detection of multidrug resistance among persons with presumptive pulmonary TB in China.Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study.Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individualsSputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppressionDo adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluidComparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study.Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosisEffects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa.Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden.Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda.Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis.Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study.Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence surveyA diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru.
P2860
Q22241307-67573E0F-C089-4F8F-BA23-27613E31FD75Q24200879-DE5BEF27-9C05-4E3D-9951-D23FE001FE29Q24201466-5616A6BF-793C-4561-9C23-CEB9CC17643BQ27004667-632CD646-98E2-4CB4-961F-A530F90B73ACQ28479276-985264B0-6767-4665-BB2A-F27EC8440D1AQ28485194-39F8FEEA-357D-4171-A5CC-FDA7E5C68F2FQ28485280-075031F3-280A-46D6-AAE9-43F083A1DA30Q28533713-7D1FCDF9-A01B-484A-9FF9-4DDC1894814EQ28536945-48961A02-72D3-4499-B70E-AF69F74A7E96Q28539727-18681F93-A1BB-4AA8-8E64-1746BD6CF416Q28540488-C5E7AA44-C76B-4FF9-A3C2-7A4D5E57EA6DQ28542588-B5DEF7A3-0C1A-487B-83D5-331D11B9AEC3Q28543236-5C6C6023-2E4D-46DD-A427-0AE8DE2BD784Q28551561-EF97BFF8-5F89-4363-99CE-F8C1381F5BC1Q28727351-5C47443A-FE07-4D26-A02B-6D7AD355D98EQ28729742-CA23BA2D-998A-4F9C-8F73-A0D52A0BD20AQ30250218-55169177-1974-4B7B-B1C4-8694EB2E0501Q31106576-377712B1-66E4-4C4D-A187-C0C085CC46DFQ33569400-E68589F7-56A0-4198-A673-BC25C6E2613CQ33640495-9EA11270-E5C7-4AEE-8E03-1017655586C9Q33754205-CC8F953F-EB8B-4D25-8825-A97EA2476180Q33777355-2F7CE1ED-AF0C-4BB1-9E81-D434F19FDC8CQ33793921-EFF0C643-3B86-4692-8EB9-C32BF81D888EQ33816191-75C29714-5DFB-49BF-B62D-A17D8A25EF4FQ33820488-D832CA5B-CE57-4552-9EE2-1E2568FAE2AAQ33884141-01D6142F-1823-4167-A0AB-20C66AF580BCQ33900005-955D25AC-0D83-40BC-849C-99F5B9526825Q33901601-DB91A087-496C-4336-9F5D-3908FCC82932Q33924814-F9D8A295-791A-4D4C-923F-AD8950D3AF93Q33924841-9EAA4BC4-18A6-45AB-8B94-123085ECCE38Q33938728-35FB1133-1FAB-4B2C-B4E9-999B2068B81CQ34048848-E6D334B9-C7AC-447F-A247-87A1F656B87DQ34062760-EB2C524A-654E-4EE2-930D-913735CE6D9EQ34076574-1E8E86BF-453A-44A5-91F8-12327BAED7FFQ34116991-D71163D0-2FF7-496D-8931-05E3E670194AQ34184138-EFD2039B-3DD9-4107-9D9E-18FD269A97F4Q34298219-3FAB5693-4DEF-4102-AAF3-C288E6D15535Q34367051-2E67067B-EE9E-4FBB-A582-31472F828CD5Q34384993-667C30A6-F0D5-48C8-98E8-ED2EC0812892Q34412632-E03DADEB-C0EE-4DCC-9277-98A742CABB63
P2860
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of the Xpert MTB/RI ...... a high HIV prevalence setting.
@en
type
label
Evaluation of the Xpert MTB/RI ...... a high HIV prevalence setting.
@en
prefLabel
Evaluation of the Xpert MTB/RI ...... a high HIV prevalence setting.
@en
P2093
P2860
P50
P1476
Evaluation of the Xpert MTB/RI ...... a high HIV prevalence setting.
@en
P2093
Andrew Whitelaw
Grant Theron
Hridesh Mishra
Jonny Peter
Rodney Dawson
Samuel Murray
Surendra Sharma
P2860
P304
P356
10.1164/RCCM.201101-0056OC
P407
P50
P577
2011-04-14T00:00:00Z